Skip to main content

NinePointTwo Capital

SEC CIK
0001824516
Latest filing
Feb 14, 2024

TPTX holding history

Turning Point Therapeutics, Inc. in every 13F filed by NinePointTwo Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TPTX overviewAll 13F holders of TPTXFull Q4 2023 holdings

Shares (Q2 2022)
0
Sold out in Q2 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q1 2022
Holdings of TPTX by NinePointTwo Capital, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20220$00.0%−18,375−100.0%Sold outHolders
Q1 202218,375$493.0K0.1%+18,375NewHolders